Jubilant Life May BuyBack Eli Lilly's Stake In Drug Discovery JV
by Irfan Khan
@JubilantLifeSciences may buyback Eli Lilly & Company's stake in their drug discovery JV - Vanthys Pharmaceuticals as both the partners have decided to calloff the partnership. According to ET, Jubilant will absorb the two dozen-odd employees, mostly scientists working at the centre.
Bangalore based Vanthys Pharmaceuticals was formed in 2008 as a 50:50 JV between the two to develop molecules from the pre-clinical to phase II stage across oncology, diabetes and cardiovascular segments.
At the time of the announcement, the two firms had said they would jointly invest $8Mn in the Bangalore-based firm over the next three years.
Initially, Jubilant Life Sciences and Eli Lilly had begun work on about a dozen molecules, transferred from their respective research portfolio into the JV. The two companies will retain intellectual property of their respective molecules.
Johnson&Johnson is planning to sell of its two FMCG brands which include Savlon antiseptic soap and liquids, and Shower to Shower talcum powder brands in India for a consideration value of above INR 3000 Mn.
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.